Indoco Remedies Sees 4% Gain on EU GMP Approval, Bata India Declines 3% After Disappointing Q4 Earnings
Market Activity Drives Stock Prices on May 29
Several stocks remained in focus on May 29 as corporate developments, earnings announcements, and regulatory triggers continued to drive market activity.
Bata India shares fell 3 percent after the company reported a sharp decline in Q4 earnings. Consolidated profit plunged 95.2 percent year-on-year to Rs 2.2 crore from Rs 45.9 crore, while revenue rose 5 percent to Rs 827.6 crore against Rs 788.2 crore in the corresponding quarter last year.
| Company | Q4 Revenue (Year-Ago) | Q4 Revenue (Current Year) | Revenue Growth |
|---|---|---|---|
| Bata India | Rs 788.2 crore | Rs 827.6 crore | 5% |
Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data
In contrast, PhysicsWallah shares gained 3 percent after the company narrowed its Q4 consolidated loss to Rs 74.9 crore from a loss of Rs 293.1 crore a year ago. Revenue jumped 50.7 percent year-on-year to Rs 918.8 crore from Rs 609.6 crore.
| Company | Q4 Loss (Year-Ago) | Q4 Loss (Current Year) | Revenue Growth |
|---|---|---|---|
| PhysicsWallah | Rs 293.1 crore | Rs 74.9 crore | 50.7% |
Ashok Leyland shares slipped 2 percent despite the company posted strong Q4 earnings. Consolidated profit increased 14.2 percent to Rs 1,290.7 crore from Rs 1,130.1 crore, while revenue surged 17.4 percent to Rs 17,246.4 crore from Rs 14,695.6 crore year-on-year.
PC Jeweller shares moved higher by 10 percent after the company reported robust Q4 performance. Consolidated profit soared 61.3 percent to Rs 152.9 crore from Rs 94.8 crore, while revenue climbed 32.7 percent to Rs 927.3 crore from Rs 699 crore in the year-ago period.
Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline
| Company | Q4 Profit (Year-Ago) | Q4 Profit (Current Year) | Revenue Growth |
|---|---|---|---|
| PC Jeweller | Rs 94.8 crore | Rs 152.9 crore | 61.3% |
Indoco Remedies shares rose 4 percent after the company received EU GMP certification from the German Health Authority (Berlin) for its Oral Solid Dosage manufacturing facility at Baddi, Himachal Pradesh. The inspection was conducted from April 22 to April 27, 2026.
Market participants said that news flow remains a key driver in the current market environment, with investors closely monitoring corporate announcements and sector-specific developments. As the earnings season progresses, company-specific updates are expected to continue driving stock-specific volatility.
Investor Takeaway
Investors should be cautious of Q4 earnings announcements and their impact on stock prices.
More in Market
Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data
US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline
Indian Stocks to Watch: BHEL, Agarwal Industrial, JBM Auto, Rajesh Exports, Indian Energy Exchange, Lenskart Solutions in Market Focus on June 4.
